PEDIATRIC LATE OUTCOMES PROTOCOL ACTG 219C

儿科晚期结果方案 ACTG 219C

• 批准号: 7375327
• 负责人: Sharon A Nachman
• 金额: $ 12.46万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375327
• 关键词: PEDIATRIC; LATE; OUTCOMES; PROTOCOL; ACTG

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to follow all infants, children and adolescents who are seen at Pediatric AIDS Clinical Trials Group sites as well as infants born to HIV-infected mothers who were enrolled in a PACTG drug study when they were pregnant, to look for long-term benefits or any late, harmful effects of medications or vaccines taken. All children are eligible to be followed until at least their 24th birthday.

本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是中心的，不一定是研究者的机构。本研究的目的是跟踪所有在儿科艾滋病临床试验组就诊的婴儿、儿童和青少年，以及艾滋病毒感染的母亲在怀孕期间参加了PACTG药物研究的婴儿，以寻找长期益处或所服用药物或疫苗的任何后期有害影响。所有的孩子都有资格被跟踪到至少24岁。